Immunotherapy agent benefits patients with drug-resistant multiple myeloma
In its first clinical trial, a breakthrough antibody therapy produced at least partial remissions in a third of patients with multiple myeloma who had exhausted multiple prior treatments, investigators at Dana-Farber Cancer ...
Aug 26, 2015
0
51